Kowa Company, Ltd.

13 clinical trials · Sponsor

Record	Firm	Date
A Post-Marketing Clinical Trial of Pemafibrate in Patients ｗith Hypercholesterolemia and Inadequate Response to Statins (NCT07634484)	Kowa Company, Ltd.	2026-07-01
A Phase III Confirmatory Study of K-237 (NCT05056883)	Kowa Company, Ltd.	2021-10-22
A Phase 3 Study to Evaluate the Efficacy and Safety of K-877 in Chinese Patients With High TG and Low HDL-C (NCT04998981)	Kowa Company, Ltd.	2021-09-17
A Phase III Confirmatory Study of K-877 Extended Release Tablet (NCT04714151)	Kowa Company, Ltd.	2021-02-01
A Phase III Long Term Study of K-877 Extended Release Tablet (NCT04716595)	Kowa Company, Ltd.	2021-02-01
K-924 Phase III Confirmatory Study (NCT04289649)	Kowa Company, Ltd.	2020-04-02
K-924 Phase III Long Term Study (NCT04289662)	Kowa Company, Ltd.	2020-03-23
A Clinical Pharmacology Study of K-877 Controlled Release Tablet (NCT04079530)	Kowa Company, Ltd.	2019-09-13
A Study to Evaluate the Safety of K-755 in Healthy Volunteers (NCT03414294)	Kowa Company, Ltd.	2018-02-27
A Study of Pemafibrate in Patients With Nonalcoholic Fatty Liver Disease (NAFLD) (NCT03350165)	Kowa Company, Ltd.	2017-12-27

Every clearance here is in the API, with alerts when new ones post.